Programme 2019

Opening remarks
09:00Opening and welcomePeter Reiss (SHM; Amsterdam UMC, UvA; AIGHD, Amsterdam)
Session 1: Advances and Barriers in Optimising HIV Care
Chairs: Jan Prins (Amsterdam UMC, AMC site, Amsterdam) & Jet Gisolf (Rijnstate, Arnhem)
09:10 - 09:40Plenary: ART: a changing landscapeProf. Chloe Orkin (Barts Health NHS Trust, London, UK)
09:40 - 09:50Large cost-savings of splitting a single-tablet regimen (STR) to a two-tablet regimen (TTR), containing the same antiretroviralsPiter Oosterhof (OLVG, Amsterdam; Radboudumc, Nijmegen)
09:50 - 10:00Substantial transmission of the M28V resistant associated variant among acute hepatitis C HIV co-infected men-who-have-sex-with-menStephanie Popping (Erasmus MC, Rotterdam)
10:00 - 10:10HIV as a chronic condition: Experienced burden of living with HIV today among men who have sex with men in the NetherlandsWard van Bilsen (GGD Amsterdam, Amsterdam)
10:00 - 10:20Reasons for late presentation among older MSM in Amsterdam Maarten Bedert (AIGHD; GGD Amsterdam, Amsterdam)
10:20 - 11:05Moderated panel discussion: Highlights from the 2019 HIV Monitoring ReportModerator: Alexander Pastoors (Hiv Vereniging)
Speakers: Ard van Sighem, Anders Boyd, Colette Smit en Ferdinand Wit (SHM, Amsterdam)
Panel: Jan Prins (Amsterdam UMC, AMC site), Jet Gisolf (Rijnstate, Arnhem), Gerjanne ter Beest (Rijnstate, Arnhem)
11:05 - 11:35Refreshment break & poster viewing
Session 2: From Conception to Infancy and Beyond
Chairs: David Burger (Radboudumc, Nijmegen) & Liesbeth van Leeuwen (Amsterdam UMC, UvA, Amsterdam)
11:35 - 12:05Plenary: Challenges and needs for women living with HIV: From conception to infancyDr. Karoline Aebi-Popp (University Hospital Bern, Switzerland)
12:05 - 12:15White matter hyperintensity expansion in long-term treated perinatally HIV-infected adolescents: a longitudinal neuroimaging study.Malon van den Hof (Amsterdam UMC, UvA, Amsterdam)
12:15 - 12:25Cerebral organoids as a novel 3D cell culture model to investigate the neuropathogenesis of HIVStephanie Gumbs (UMC Utrecht, Utrecht)
12:25 -13:45Lunch and poster viewing + guided walk tours
Session 3: Science to Advance the Response
Chairs: Peter Reiss (SHM; Amsterdam UMC, AMC site; AIGHD, Amsterdam) & Monique Nijhuis (UMC Utrecht, Utrecht)
13:45 - 14:15Keynote: Ending the HIV Pandemic: Challenges and OpportunitiesDr. Anthony Fauci (NIH/NIAID, Bethesda, USA)
14:15 - 14:25Genetic variations in the host dependency factors ALCAM and TPST2 impact HIV-1 disease progressionZita Kruize (Amsterdam UMC, UvA, Amsterdam)
14:25 - 14:35Harm reduction revisited: The causal effect of the Dutch approach towards people who inject drugs on HIV infection risk in Amsterdam, the NetherlandsAnders Boyd (GGD Amsterdam, Amsterdam)
14:35 - 14:45Sexual behaviour and perceived risk of HIV between 1999 and 2018 among men who have sex with men in Amsterdam, the NetherlandsGanna Rozhnova (UMC Utrecht, Utrecht)
14:45 - 14:55Inducing cell death: an approach to selectively target viral RNA expressing cells to eliminate the HIV-1 reservoirShringar Rao (Erasmus MC, Rotterdam)
14:55 - 15:05Repurposing of clinically-approved autophagy drugs for combinatory prophylactic and therapeutic HIV-1 therapiesAlexandra Cloherty (Amsterdam UMC, UvA, Amsterdam)
15:05 - 15:40Refreshment break
Session 4: From the Bench to the Community
Chairs: Kim Sigaloff (Amsterdam UMC, VUmc site) & Eric van Gorp (Erasmus MC, Rotterdam)
15:40 - 16:10Plenary: Bringing precision to the global HIV responseProf. Wafaa El-Sadr (Columbia University, New York, USA)
16:10 - 16:20Antibodies from rabbits immunized with clade B SOSIP trimers can neutralize despite unusual approach anglesMarlies van Haaren (Amsterdam UMC, UvA, Amsterdam)
16:20 - 16:30Comparison of monoclonal antibodies induced by HIV-1 envelop glycoprotein immunization and SHIV infection in non-human primates to guide HIV vaccine designJelle van Schooten (Amsterdam UMC, UvA, Amsterdam)
16:30 - 16:40Frequency and determinants of switching between daily and event-driven PrEP and discontinuing each regimen among men who have sex with men participating in the Amsterdam PrEP demonstration projectLiza Coyer (GGD Amsterdam, Amsterdam)
16:40 - 16:50Offering a choice of daily and event-driven PrEP for MSM: a cost-effectiveness analysisAlbert Jan van Hoek (RIVM, Bilthoven)
16:50 - 17:00Using a daily mobile application and dried blot spots to measure adherence to event-driven PrEP among participants of the AMPrEP cohort studyVita Jongen (GGD Amsterdam, Amsterdam)
17:00 - 17:15Closing & presentation of Joep Lange and Jacqueline van Tongeren young investigator awardPeter Reiss (SHM; Amsterdam UMC, UvA; AIGHD, Amsterdam)